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Economic transitions in the era of globalization warrant a fresh look at the neurological risks associated with environmental 
change. These are driven by industrial expansion, transfer and mobility of goods, climate change and population growth. In these 
contexts, risk of infectious and non-infectious diseases are shared across geographical boundaries. In low- and middle-income 
countries, the risk of environmentally mediated brain disease is augmented several fold by lack of infrastructure, poor health and 
safety regulations, and limited measures for environmental protection. Neurological disorders may occur as a result of direct 
exposure to chemical and/or non-chemical stressors, including but not limited to, ultrafine particulate matters. Individual sus-
ceptibilities to exposure-related diseases are modified by genetic, epigenetic and metagenomic factors. The existence of several 
uniquely exposed populations, including those in the areas surrounding the Niger Delta or north western Amazon oil operations; 
those working in poorly regulated environments, such as artisanal mining industries; or those, mostly in sub-Saharan Africa, re-
lying on cassava as a staple food, offers invaluable opportunities to advance the current understanding of brain responses to en-
vironmental challenges. Increased awareness of the brain disorders that are prevalent in low- and middle-income countries and 
investments in capacity for further environmental health-related research are positive steps towards improving human health.
Nature 527, S187-S192 (19 November 2015), DOI: 10.1038/nature16034 
This article has not been written or reviewed by Nature editors. Nature accepts no responsibility for the accuracy of the information provided.
R eports from the World Health Organization (WHO) indicate that the global burden of disease is determined by patterns of disease and disability in low- and middle-income countries (LMICs), 
which, predictably, have their own environmental signatures (http://
www.who.int/healthinfo/global_burden_disease/about/en/). How-
ever, the effect of such signatures on both brain health and region or 
global disability-adjusted life years (DALYs) remains unknown and 
needs to be added to the agenda of global environmental health re-
search. As for high-income countries, environmental health research 
programmes in LMICs must primarily focus on elucidating the entire 
range and source of exposures to define the human ‘exposome’ (the 
measure of all the exposures of an individual in their lifetime and how 
these exposures relate to health) relevant to brain health in LMICs. The 
research agenda should also include mechanistic and translational re-
search, as well as capacity building to foster a new generation of envi-
ronmental health scientists. 
SCOPE
In this Review, we focus on environmental risk factors for brain diseases 
and conditions in LMICs (http://data.worldbank.org/about/country-
and-lending-groups). An iterative search of the literature was con-
ducted using PubMed to retrieve information related to environmental 
determinants and mechanisms of brain disease in LMICs. Additional 
opinion was obtained from interviews with leading environmental 
scientists and neuroscientists, as well as programme officers at the US 
National Institutes of Health and US National Institute of Environmen-
tal Health Sciences (NIEHS), and Fogarty International Center. This 
Review integrates the goals and approaches to environmental health 
research as per the NIEHS 2012–2017 strategic plan (https://www.
niehs.nih.gov/about/strategicplan/). 
ENVIRONMENTAL EXPOSURE AND BRAIN HEALTH 
LMICs are home to around 80–85% of the world’s population1. Of these 
5.8 billion people2, 1 billion remain in extreme poverty, living below the 
US$1.25 per day poverty line3. Around 3 billion people do not have piped 
drinking water in their home and 173 million people rely on the direct 
use of surface water. Without proper sanitation, about one billion con-
tinue to defecate in gutters, in the open bush or in open water bodies4. 
Wildfires and deforestation are commonplace and drought and floods, 
possibly due to climate change, degrade the existing farming systems 
and create food insecurity5–7. Armed conflicts and population displace-
ments impose a toll on human life8. Industrial expansion coexists with 
an unprecedented rise in artisanal mining and unprotected labour9. 
In some instances, normal urbanization operations, such as road con-
struction and quarantines (for example during Ebola outbreaks in the 
Democratic Republic of the Congo) have created conditions that exac-
erbated the risk of environmental exposure and brain disease10. Flawed 
regulations compounded by a lack of infrastructure set the stage for 
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environmental degradation and pollution to pose serious threats — of a 
chemical or non-chemical nature — to human health. The degradation 
of local ecosystems leads to the creation of ‘microenvironments’ that 
have a high risk of harmful exposures, often resulting in unique chal-
lenges and increased risk of human disease (Fig. 1). 
HIGH-RISK POPULATIONS AND MICROENVIRONMENTS 
Risk of exposure-related brain disease is determined by age, gender 
and microenvironments created by natural disasters in which eco-
nomic, social and cultural determinants of health often have impor-
tant roles. One example of a profit-mediated environmental risk is that 
caused by the oil industry through accidental spills or mismanagement 
of oil operations. For instance, crude oil operations have polluted large 
areas of rainforests, including streams and rivers in Ecuador, Peru 
and Colombia11. The population of Nigeria has faced similar challenges 
owing to reoccurring oil spills as a result of ageing, ill-maintained or 
sabotaged pipelines in the Niger Delta. The impact of such man-made 
and preventable natural disasters on human health has yet to be deter-
mined. Effects on human health will depend on the type and composi-
tion of the spilled oils, which often contain a mixture of polycyclic hy-
drocarbons that are known to be toxic to the nervous system11. Oil spills 
arise owing to reasons, such as a lack of vigilance, neglect of necessary 
health and safety checks, or sometimes even promotion of commercial 
interests at the expense of communities. Symptoms of acute exposure 
to raw oil include consistent episodes of headache, nausea, dizziness 
and fatigue. Chronic effects include psychological disorders, endocrine 
abnormalities and genotoxic effects12.
Microenvironments in which the population has a higher suscep-
tibility to exposure-related diseases have also been created by extreme 
poverty and natural disasters, including drought and flooding that can 
degrade soils, plants and farming operations. The burden of conven-
tional neurodevelopmental stressors (for example, lead) on children 
is exacerbated by unique environmental challenges, including mal-
nutrition and enteric infections13–16 and, possibly, a diet of neurotoxi-
cant-containing plants such as cassava (Manihot esculenta; also known 
as tapioca), the grass pea Lathyrus sativus or the seeds from the cycad 
plants, which are all known to be associated with a high burden of neu-
rodisabilities at a population level17–22. Populations with unique expo-
sures and risks include those living in the tropical cassava belt of Ango-
la, the Central African Republic, Cameroon, Congo, Tanzania, Uganda, 
Nigeria and Mozambique23–30; those reliant on L. sativus as a staple food 
in Ethiopia, Eritrea, India and Bangladesh20,31–33; and the people of the 
Pacific island Guam or the Japanese Kii Peninsula where the rates of 
environmentally linked syndromes such as amyotrophic lateral sclero-
sis-parkinsonism-dementia complex (ALS/PDC) have been declining 
for reasons that have yet to be uncovered34,35. 
The impact of early childhood diseases that lead to a vicious cycle of 
enteric infections and malnutrition has been underestimated and ne-
glected, especially in areas that lack acceptable levels of hygiene and 
sanitation and that have reduced accessibility to vaccines and antimi-
crobials. This has caused clinically silent, chronic-illness-related ef-
fects, which jeopardize the child’s full cognitive development13,15. This 
vicious cycle establishes what is called environmental enteropathy, a 
mostly subclinical condition (even without diarrhoea) caused by var-
ious degrees of intestinal barrier dysfunction, luminal-to-blood in-
testinal bacterial translocation, low-grade local and systemic inflam-
mation, and disrupted innate intestinal immune responses that may 
affect growth36 and cognition37 and possibly lead to neurodegeneration 
as well as liver, and metabolic diseases later in life38,39. 
Adolescents in LMICs experience a higher burden of exposures (in 
contrast with those in high-income countries), primarily because of 
the childhood labour crisis. Although there are regulations and inter-
national agreements restricting child labour, often there are exceptions 
for certain industries, notably the growing agricultural industry, one 
of the most hazardous industries worldwide40,41. In this context, ado-
lescent workers are at risk of exposure to agrochemicals such as pesti-
cides42,43. Other work-related threats include exposure to organic sol-
vents in work that involves painting and manufacture, to toxic metals 
and fine particulate matters in artisanal mining, and to heat and am-
bient air pollution while working long hours and outside41. Exposure to 
Table 1 | Heavy metals and exposure-related outcomes
Heavy metal Source of exposure Susceptibility window Neurological outcomes Proposed mechanisms 
Lead76–78 Lead-contaminated dust, lead-based 
paint, soil, drinking water, air, leaded 
gasoline, toys and lead-contaminated 
sweets
Lifelong Visual and verbal memory decline, 
intellectual deficits, decline in 
executive functioning (fine motor 
function, hand-eye coordination and 
reaction time) and hyperactivity in 
children
Disruption of neurotransmitter 
release and function, and prenatal 
disruption of neuronal migration and 
differentiation; aggravating factors 
include poor nutrition (deficiency in 
iron, zinc and calcium) and younger 
age
Mercury79,80 Mining industry, power plants, 
crematoria, charcoal industry, and 
contaminated food (mostly sea food) 
and water
From neural development to 
neurulation, and adolescence 
Ataxia in adults and language, 
attention, and visuospatial 
performance deficits in children
Oxidative stress or impairment of 
intracellular calcium and glutamate 
homeostasis
Arsenic80,81 Contaminated food and drinking 
water, air and arsenic-based 
treatments
5–15 years Impaired selective and focused 
attention and long-term memory 
in children, and sensorimotor 
polyneuropathy
Oxidative stress or disruption of 
metabolism of neurotransmitters
Copper82 Contaminated drinking water and 
food, uncoated copper cookware and 
infant formula containing copper
Children
Those over 65
Alzheimer’s disease, OCD, ADHD, 
antisocial behaviour and anxiety in 
children
Oxidative stress, microglia 
cell activation or promotion of 
α-synuclein and fibril formation
Cobalt82,83 Contaminated drinking water and 
food, inhalation of dust containing 
cobalt particles in various industries
Prenatal, young children and the 
elderly
Optic, auditory and peripheral 
neuropathy, motor deficits and verbal 
memory loss 
Alteration of mitochondrial oxidative 
phosphorylation or depletion of 
neurotransmitters 
Cadmium83 Fumes or dust, cigarette smoke, and 
contaminated food and water
Prenatal, young children and the 
elderly
Antisocial behaviour and attention 
impairment in children, parkinsonism 
and peripheral neuropathy
Oxidative damage and 
neurotransmitter disruption 
Manganese76,79 Airborne as fumes, aerosols or 
suspended particulate matter and 
contaminated water
Childhood and the elderly Reduced IQ, impaired verbal learning 
and working and immediate memory 
in children, and Parkinson-like 
symptoms
Disruption of mitochondrial 
respiratory chain reaction; 
aggravating factors include iron 
deficiency and impaired biliary 
excretion (liver injury or disease)
Aluminium84 Contaminated air, water and food, 
cosmetics (such as antiperspirants), 
metal industries and pharmaceuticals
Lifelong Alzheimer’s pathology in the form of 
neurofibrillary tangles
Disruption of mitochondrial 
respiratory chain reaction or 
inflammation; zinc deficiency 
acknowledged as an aggravating 
factor
ADHD, attention-deficit hyperactivity disorder; OCD, obsessive compulsive disorder.
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industrial solvents such as n-hexane, for example, may occur because 
of poor safety regulations or recreational glue sniffing. This may result 
in headache, acute encephalopathy or sensorimotor neuropathies that 
are reversible on cessation44. 
Adults in LMICs may be at a particularly high risk of environmental 
exposure and related brain diseases compared with those in high-in-
come countries. In general, they experience a higher burden of disease 
owing to a lifetime of cumulative exposures and co-morbidities that are 
highly prevalent in LMICs. The latter include malaria, nutritional de-
ficiencies and neurotropic infections such as those caused by human 
T-cell lymphotropic viruses (HTLV). For example, it was reported that 
endemic foci of HTLV-I-associated myelopathy coexist with outbreaks 
of konzo (a spastic paraparesis linked to the toxicity of cassava cyano-
gens) in some regions of the Congo45,46. In these areas, women of child-
bearing age are particularly susceptible to the toxicity of cassava cyano-
gens for reasons that have not been elucidated, although they may be 
linked to hormonal influences and poor nutrition47.
PATHWAYS TO BRAIN DISEASE 
Exposure-related brain damage may result from chemical and/or 
non-chemical stressors. Damage to the nervous system often leads 
to a range of bilateral and symmetrical motor and/or sensory symp-
toms. Behavioural problems, cognition deficits and psychiatric illness 
may also occur. Non-chemical stressors include, but are not limited to, 
psychological stress, heat, noise, fine and ultrafine particulate matter 
(FUPM), and waterborne, airborne or foodborne pathogens that may 
occur under the conceptual framework shown in Fig. 1. Chemicals with 
neurotoxic potential that people are commonly exposed to are listed 
in Tables 1–3. Mixed exposure, for example chemical-covered FUPM 
from industrial emissions; co-exposure to chemical and non-chemi-
cal stressors; and repeated and multiple exposure can occur, creating a 
complex human environmental exposome. 
Brain damage linked to chemical exposure may result from chem-
icals interfering with neurotransmission through molecular mimicry 
or reacting with crucial biomolecules and causing incorrect function 
(for example, protein or DNA adduction and/or crosslinking). For 
both chemical and non-chemical exposures, the mechanisms of brain 
damage may include injury to the vascular system (for example, fine 
particulate matter induced vascular pathology), systemic dyshomeo-
stasis (for example, cadmium-induced kidney disease) and hormonal 
imbalance (for example, through endocrine disruption; Table 1). 
The susceptibility to exposure-related disease is, however, de-
termined by mechanisms of functional genetics, epigenetics and 
metagenomics at the interface between risk factors and neurological 
outcomes (Fig. 2). 
It is increasingly acknowledged that genetic and epigenetic factors, 
including the effect of maternal stress on brain function, influence the 
effect of environmental exposure48,49. For example, the E4 allele of the 
APOE gene that is reportedly associated with higher risk of late-onset 
Alzheimer’s disease, although not in people from sub-Saharan Africa 
and with a mild association among Hispanic people, is associated with 
protection against early childhood diarrhoea and its related cognitive 
Table 2 | Organic compounds and exposure-related outcomes
Organic compound Source of exposure Susceptibility window Neurological outcomes Proposed mechanisms 
Bisphenol A85,86 Food from cans with linings that 
contain BPA, and contaminated food 
and water
Prenatal and childhood Anxious behaviour, hyperactivity and 
depressive behaviour, and learning 
impairment in children 
Unclear, but females seem to be more 
susceptible
Phthalates86–88 Food or drink that has been in 
contact with containers or products 
containing phthalates, and air and 
dust containing phthalates
Prenatal and childhood Depressive and conduct-related 
behaviours (ODD, attention 
problems, rule-breaking and 
aggressive behaviour in children)
Oxidative stress
Organophosphates89,90 Contaminated food and water, 
polluted air and professional dermal 
contact 
Lifelong Neurodevelopmental deficits, 
impaired attention and working 
memory, impaired speed and 
executive functions, and delayed 
peripheral polyneuropathy
Inhibition of acetyl-cholinesterase
Organochlorinated compounds 
(DDT/PCBs)91 
Contaminated food, drinking water 
and air
Prenatal and lifelong Impaired intellectual ability, ADHD-
like behaviours and locomotor 
deficits
Disruption of neurotransmitter 
function, oxidative stress 
or derangement of calcium 
homeostasis; children seem to be 
more susceptible.
Organobromide compounds 
(PBDEs)92,93 
Contaminated food, water and air Lifelong IQ deficits, impaired attention, fine 
motor coordination and cognition 
functioning in children 
Impairment of thyroid hormone 
homeostasis
Organic solvents94,95 Air and professional dermal contact 
and glue sniffing 
Adolescence and adulthood Headache, memory deficits, and 
central and peripheral neuropathy
Protein adduction and/or oxidative 
misfolding or oxidative stress
Food-born neurotoxicants 
(cassava cyanogenic glucosides 
and BOAA in Lathyrus 
sativus)96–98  or contaminants 
(fungal toxins) 
Oral ingestion Lifelong Spastic paraparesis, cognition deficits 
and possibly convulsive disorders 
Oxidative stress, excitotoxicity and 
protein carbamylation for cassava 
cyanogens; children and females 
seem to be more susceptible; 
malnutrition is acknowledged as an 
aggravating factor 
ADHD, attention-deficit hyperactivity disorder; BOAA, beta-(n)-oxalyl-amino-l-alanine acid; BPA, bisphenol A; DDT/PCBs, dichlorodiphenyltrichloroethane/polychlorinated biphenols; ODD, oppositional 
defiant disorder.
Table 3 | Complex exposures and neurological outcomes
Exposure Source of exposure Susceptibility window Neurological outcomes Proposed mechanisms 
Coal/charcoal burning99,100 Charcoal/coal combustion, gas 
grilling, wood smoke, or coal mine 
dust or ash
Lifelong Neurological signs of exposure to 
arsenic
Oxidative stress
Car emissions101,102 Contaminated air Lifelong Learning disability and motor 
impairment
Oxidative stress or neurotransmission 
disruption
Fine and ultrafine particulate 
matters103 
Air pollution from car or construction 
equipment exhausts, wood burning, 
heating oil or coal, forest fires, 
volcanic eruptions, tobacco smoke 
and cooking 
Lifelong Behavioural and decreased IQ, 
impaired fluid cognition, memory 
and executive functions, and possibly 
autism
Oxidative stress, neurotransmission 
disruption or neuroinflammation
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impairment50–52. One example of gene–environment interactions is the 
relationship between air pollution components and the gene encod-
ing the MET receptor tyrosine kinase. Several studies have implicated 
MET as an autism risk gene53–55. Stratification of the risk conferred by a 
functional promoter variant in this gene (rs1858830) and by local traf-
fic-related air pollution (regional particulate matter less than 10 mi-
crometres in diameter and nitrogen dioxide exposure) revealed signif-
icant multiplicative interaction between the risk genotype and the air 
pollution exposure56. 
Our knowledge of the pathways that lead to late onset of expo-
sure-related neurological disease is still sparse57,58. Many studies sug-
gest that the genetic and environmental causes of late onset diseases 
act in parallel and share common molecular mechanisms59. A number 
of studies have supported the concept that early-life exposure to pol-
lutants reprograms global gene expression in old age through epige-
netic mechanisms60–63. Variation in exposure response, even among 
individuals exposed to the same environment could be due not only 
to early-life exposures, but also to differences in genetic make up64–66. 
The extent and nature of exposures and related brain diseases in LMICs 
provide opportunities to explore and overcome the long reach that 
childhood exposure has into adulthood, as well as provide us with new 
advances in environmental health sciences67.
Exposure-related neurological deficits in LMICs range from pe-
ripheral neuropathies to a large number of acute, subacute or chron-
ic central nervous system diseases. Deficits may occur prenatally, or 
during childhood or adolescence, and may be carried through to old 
age. Clinical implications include, but are not limited to, neural tube 
defects, learning disabilities, behavioural problems, psychiatric dis-
orders, cognitive decline and the occurrence of distinct entities such 
as neurolathyrism, tropical ataxic neuropathy, ALS/PDC and kon-
zo20,30,35,68,69 (Fig. 3).  
The human microbiome may be of particular interest to the mech-
anistic understanding of exposure-related diseases in LMICs because it 
may influence the burden of heavy metals70, the metabolism of food-
borne neurotoxicants such as cassava cyanogens18, and the outcome of 
enteric diseases in early life, including the child’s neurodevelopmental 
potential71–73. 
RESEARCH AND CAPACITY BUILDING
Recent advances in environmental health sciences have elucidat-
ed the myriad risk factors and mechanisms of brain damage that are 
associated with environmental exposures. The existence of uniquely 
exposed populations in LMICs offers invaluable opportunities to ad-
vance our current understanding of brain responses to environmental 
threats. In some instances, well-characterized neurotoxicants may be 
used as chemical probes to dissect the pathophysiology of the nerv-
ous system. However, challenges at the population level still remain, 
including setting exposure limits and developing metrics and meth-
odologies to assess the long-term impact of environmental exposures 
on disease burden in LMICs and, therefore, globally. Climate change 
and mining of rare elements, which may include radioactive materials, 
present unpredictable risks, and should be added to the environmental 
health research agenda. The toll of such exposures on the global bur-
den of disease may be efficiently addressed only through competent 
partnerships and alliances established on a global scale and focused on 
key areas and priorities (Box 1). Although there is evidence that some 
of these are already in place, more research and research capacity is 
needed to continue this agenda to improve human health, globally.    
ONE HEALTH–GLOBAL HEALTH DIMENSIONS 
Environmental degradation and contamination, changes in climate and 
ecosystems, and vector-born pathogens or neurotoxicants are the pri-
mary environmental threats to human life and intellectual performance. 
BOX 1 | INTERWOVEN RESEARCH AREAS AND IN-
VESTMENT PRIORITIES IN GLOBAL ENVIRONMEN-
TAL RESEARCH 
• Epidemiology and statistical modelling for exposure and risk 
assessment in co-exposure and co-morbidity scenarios
• High-throughput ‘-omic’ methodologies
• Bioinformatics and knowledge management
• Development of diagnostic and remediation tools — validation 
and implementation of environmental sensors, detectors and 
biomonitors of exposure and related outcomes
• Development of metrics and methodologies to assess the long-
term impact of environmental exposures on neurological disease 
burden
• Understanding the pathways that lead to late onset of exposure-
related neurological diseases 
• Training and capacity building in the areas listed above
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Figure 1 | Environmental (chemical and non-chemical) threats to brain health in low- and middle-income countries. Multiple sources of exposure (air, water and 
food) coexist, and malnutrition and vector-borne diseases, notably infections, compound the risk of brain disease. Co-exposures not shown include heat, psycho-
logical stress and a poor physical environment, such as crowding.  
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Humans, plants and animals adapt to environmental challenges, but 
some may overcome their adaptive capabilities and create imminent 
risks for all17,74. Strategies to promote human health will therefore re-
quire a serious commitment to trans-disciplinary work, plant and ani-
mal health and building capacity on a global scale75.
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